Recently, many studies have suggested that low-grade gliomas (LGGs, WHO grade 2) including astrocytoma (As), oligodendroglioma (OG) and oligoastrocytoma (OA) display a highly methylated profile, in particular LGGs with mutated IDH1[20], [21]. The gene discussed is IDH1; the disease is central nervous system cancer.